tiprankstipranks
Aclaris Therapeutics (ACRS)
NASDAQ:ACRS
US Market
Want to see ACRS full AI Analyst Report?

Aclaris Therapeutics (ACRS) Blogger Opinions & Sentiment

928 Followers

Blogger Sentiment

Neutral 50.00%
Sector Average
Neutral
ACRS Blogger sentiment is based on 2 Blogger Opinions. The Blogger sentiment is more Bearish than other stocks in the Healthcare sector.

Blogger Article Distribution

ArticleDistribution
50% GuruFocus
50% Investing
The distribution of articles among the main online Financial Blogging platforms.

Top Blogger Bearish Predictions

Is Aclaris Therapeutics Inc (ACRS) Significantly Overvalued After Q2 Earnings Miss? Revenue at $1.6M vs. $1.38M Estimated -- GF Score: 33/100
GuruFocus
Recent negative articles by top bloggers.

Top Blogger Bullish Predictions

Not enough top blogger opinions at this time
Please return soon. This page is being updated.
Recent positive articles by top bloggers.

Financial Blogger Predictions​​

Blogger Performance
Any
Any
Blogger Sentiment
Any
Any
Blogger Name
Blogger Rank
Blog
Date
Blogger Sentiment​
Article
Follow

FAQ

What do Seeking Alpha bloggers think of ACRS?
Currently there's no blogger sentiment for ACRS.
What do Motley Fool contributors think of ACRS?
Currently there's no blogger sentiment for ACRS.
What Is ACRS’s Blogger Sentiment?
ACRS’s Blogger Sentiment is Neutral.
    What was the most recent blogger prediction for ACRS?
    The most recent blogger prediction for ACRS was made by NASDAQ:ACRS, who was Bullish on the stock.
      How can I follow the stock ratings of top Top Financial Bloggers?
      Head over to our Expert Center to see a list of the Top 100 Financial Bloggers and follow the financial bloggers of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
        Stocks with the Highest Top Blogger Ratings in the Healthcare sector
        IOVAIovance Biotherapeutics
        VERAVera Therapeutics
        KURAKura Oncology
        NUVBNuvation Bio
        DFTXDefinium Therapeutics